Articoli con mandati relativi all'accesso pubblico - Giorgio GandagliaUlteriori informazioni
Non disponibili pubblicamente: 27
EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent
N Mottet, RCN van den Bergh, E Briers, T Van den Broeck, ...
European urology 79 (2), 243-262, 2021
Mandati: Cancer Research UK, UK Medical Research Council, National Institute for …
EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II—2020 update: treatment of relapsing and metastatic prostate cancer
P Cornford, RCN van den Bergh, E Briers, T Van den Broeck, ...
European urology 79 (2), 263-282, 2021
Mandati: Cancer Research UK, UK Medical Research Council, National Institute for …
Distribution of metastatic sites in patients with prostate cancer: a population‐based analysis
G Gandaglia, F Abdollah, J Schiffmann, V Trudeau, SF Shariat, SP Kim, ...
The Prostate 74 (2), 210-216, 2014
Mandati: Fonds de recherche du Québec - Santé
Incidence, survival and mortality rates of stage-specific bladder cancer in United States: a trend analysis
F Abdollah, G Gandaglia, R Thuret, J Schmitges, Z Tian, C Jeldres, ...
Cancer epidemiology 37 (3), 219-225, 2013
Mandati: Fonds de recherche du Québec - Santé
Updated results of PURE-01 with preliminary activity of neoadjuvant pembrolizumab in patients with muscle-invasive bladder carcinoma with variant histologies
A Necchi, D Raggi, A Gallina, R Madison, M Colecchia, R Luciano, ...
European urology 77 (4), 439-446, 2020
Mandati: Fondazione AIRC per la Ricerca sul Cancro
Impact of molecular subtyping and immune infiltration on pathological response and outcome following neoadjuvant pembrolizumab in muscle-invasive bladder cancer
A Necchi, D Raggi, A Gallina, JS Ross, E Farè, P Giannatempo, ...
European urology 77 (6), 701-710, 2020
Mandati: Fondazione AIRC per la Ricerca sul Cancro
Prospective validation of gallium-68 prostate specific membrane antigen-positron emission tomography/computerized tomography for primary staging of prostate cancer
LWM van Kalmthout, HHE van Melick, J Lavalaye, RP Meijer, A Kooistra, ...
The Journal of urology 203 (3), 537-545, 2020
Mandati: Dutch Cancer Society
EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer—2024 update. Part I: screening, diagnosis, and local treatment with curative intent
P Cornford, RCN van den Bergh, E Briers, T Van den Broeck, ...
European Urology, 2024
Mandati: Cancer Research UK, National Institute for Health Research, UK, Yorkshire …
Multiparametric magnetic resonance imaging as a noninvasive assessment of tumor response to neoadjuvant pembrolizumab in muscle-invasive bladder cancer: preliminary findings …
A Necchi, M Bandini, G Calareso, D Raggi, F Pederzoli, E Farè, ...
European urology 77 (5), 636-643, 2020
Mandati: Fondazione AIRC per la Ricerca sul Cancro
Is robot-assisted radical prostatectomy safe in men with high-risk prostate cancer? Assessment of perioperative outcomes, positive surgical margins, and use of additional …
G Gandaglia, F Abdollah, J Hu, S Kim, A Briganti, JD Sammon, A Becker, ...
Journal of Endourology 28 (7), 784-791, 2014
Mandati: Fonds de recherche du Québec - Santé
Gonadotropin-releasing hormone agonists and acute kidney injury in patients with prostate cancer
G Gandaglia, M Sun, JC Hu, G Novara, TK Choueiri, PL Nguyen, ...
European urology 66 (6), 1125-1132, 2014
Mandati: Fonds de recherche du Québec - Santé
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer
D Tilki, RCN van den Bergh, E Briers, T Van den Broeck, O Brunckhorst, ...
European Urology, 2024
Mandati: Cancer Research UK, National Institute for Health Research, UK, Yorkshire …
Survival benefit of definitive therapy in patients with clinically advanced prostate cancer: estimations of the number needed to treat based on competing‐risks analysis
G Gandaglia, M Sun, QD Trinh, A Becker, J Schiffmann, JC Hu, A Briganti, ...
BJU international 114 (6b), E62-E69, 2014
Mandati: Fonds de recherche du Québec - Santé
Early radiotherapy after radical prostatectomy improves cancer‐specific survival only in patients with highly aggressive prostate cancer: Validation of recently released criteria
G Gandaglia, PI Karakiewicz, A Briganti, V Trudeau, QD Trinh, SP Kim, ...
International Journal of Urology 22 (1), 89-95, 2015
Mandati: Fonds de recherche du Québec - Santé
Can patients with muscle-invasive bladder cancer and fibroblast growth factor receptor-3 alterations still be considered for neoadjuvant pembrolizumab? A comprehensive …
A Necchi, D Raggi, P Giannatempo, L Marandino, E Farè, A Gallina, ...
European urology oncology 4 (6), 1001-1005, 2021
Mandati: Fondazione AIRC per la Ricerca sul Cancro
Conversion of robot-assisted partial nephrectomy to radical nephrectomy: a prospective multi-institutional study
S Arora, B Chun, RK Ahlawat, R Abaza, J Adshead, JR Porter, ...
Urology 113, 85-90, 2018
Mandati: UK Medical Research Council
The effect of age at diagnosis on prostate cancer mortality: a grade-for-grade and stage-for-stage analysis
G Gandaglia, PI Karakiewicz, F Abdollah, A Becker, F Roghmann, ...
European Journal of Surgical Oncology (EJSO) 40 (12), 1706-1715, 2014
Mandati: Fonds de recherche du Québec - Santé
The obesity paradox in metastatic castration-resistant prostate cancer
A Martini, QN Shah, N Waingankar, JP Sfakianos, CK Tsao, A Necchi, ...
Prostate cancer and prostatic diseases 25 (3), 472-478, 2022
Mandati: US National Institutes of Health
The value of multiparametric magnetic resonance imaging sequences to assist in the decision making of muscle-invasive bladder cancer
M Bandini, G Calareso, D Raggi, L Marandino, M Colecchia, A Gallina, ...
European Urology Oncology 4 (5), 829-833, 2021
Mandati: Fondazione AIRC per la Ricerca sul Cancro
ProstaTrend—a multivariable prognostic RNA expression score for aggressive prostate cancer
M Kreuz, DJ Otto, S Fuessel, C Blumert, C Bertram, S Bartsch, D Loeffler, ...
European Urology 78 (3), 452-459, 2020
Mandati: Fraunhofer-Gesellschaft
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software